Herceptin

Oncogramme Responses of Breast Tumour Cells Treated with Herceptin Correlate with HER2/C-ERB B2 Pathological Status.
Anticancer Res. 2012 Apr;32(4):1323-5
Authors: Giraud S, DU Puch CB, Fermeaux V, Guillaudeau A, Lautrette C…

Continue reading about Oncogramme Responses of Breast Tumour Cells Treated with Herceptin Correlate with HER2/C-ERB B2 Pathological Status.

Oncogramme Responses of Breast Tumour Cells Treated with Herceptin Correlate with HER2/C-ERB B2 Pathological Status.
Anticancer Res. 2012 Apr;32(4):1323-5
Authors: Giraud S, DU Puch CB, Fermeaux V, Guillaudeau A, Lautrette C…

Continue reading about Oncogramme Responses of Breast Tumour Cells Treated with Herceptin Correlate with HER2/C-ERB B2 Pathological Status.

Effects of a Combined Treatment With GPR30 Agonist G-1 and Herceptin on Growth and Gene Expression of Human Breast Cancer Cell Lines.
Cancer Invest. 2012 Apr 2;
Authors: Lubig J, Lattrich C, Springwald A, Häring J, Schüler…

Continue reading about Effects of a Combined Treatment With GPR30 Agonist G-1 and Herceptin on Growth and Gene Expression of Human Breast Cancer Cell Lines.

The synergistic effect of herceptin and docetaxel in polylactide-D-α-tocopheryl polyethylene glycol succinate (PLA-TPGS) nanoparticles.
J Control Release. 2011 Nov 30;152 Suppl 1:e64-5
Authors: Liu Y, Feng SS
PMID: …

Continue reading about The synergistic effect of herceptin and docetaxel in polylactide-D-α-tocopheryl polyethylene glycol succinate (PLA-TPGS) nanoparticles.

Targeting Bcl-2 in Herceptin-Resistant Breast Cancer Cell Lines.
Curr Pharmacogenomics Person Med. 2011 Sep;9(3):184-190
Authors: Crawford A, Nahta R
Abstract
Acquired resistance to Herceptin is a major clini…

Continue reading about Targeting Bcl-2 in Herceptin-Resistant Breast Cancer Cell Lines.

Novel Toll-like receptor-4 deficiency attenuates trastuzumab (Herceptin)induced cardiac injury in mice.
BMC Cardiovasc Disord. 2011 Oct 14;11(1):62
Authors: Yousif NG, Al-Amran FG
Abstract
ABSTRACT: BACKGROU…

Continue reading about Novel Toll-like receptor-4 deficiency attenuates trastuzumab (Herceptin)induced cardiac injury in mice.

Herceptin-directed nanoparticles activated by an alternating magnetic field selectively kill HER-2 positive human breast cells in vitro via hyperthermia.
Int J Hyperthermia. 2011;27(7):682-97
Authors: Zhang J, Dewilde AH, C…

Continue reading about Herceptin-directed nanoparticles activated by an alternating magnetic field selectively kill HER-2 positive human breast cells in vitro via hyperthermia.

Immobilization of a HER2 Mimotope-derived Synthetic Peptide on Au and Its Potential Application for Detection of Herceptin in Human Serum by QCM.
Anal Chem. 2011 Oct 3;
Authors: Shang Y, Singh PR, Chisti MM, Mernaugh RL, Z…

Continue reading about Immobilization of a HER2 Mimotope-derived Synthetic Peptide on Au and Its Potential Application for Detection of Herceptin in Human Serum by QCM.

Immobilization of a HER2 Mimotope-derived Synthetic Peptide on Au and Its Potential Application for Detection of Herceptin in Human Serum by QCM.
Anal Chem. 2011 Oct 3;
Authors: Shang Y, Singh PR, Chisti MM, Mernaugh RL, Z…

Continue reading about Immobilization of a HER2 Mimotope-derived Synthetic Peptide on Au and Its Potential Application for Detection of Herceptin in Human Serum by QCM.

A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients.
Hum Mol Genet. 2011 Aug 29;
Authors: …

Continue reading about A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients.